Peter M. Chumakov

Engelhardt Institute of Molecular Biology — Russia

Biochemistry, Genetics and Molecular Biology · Life Sciences

40h-index8.1kcitations226works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(85), Cancer-related Molecular Pathways(74), Cancer Research and Treatments(48), Viral Infectious Diseases and Gene Expression in Insects(20), Viral gastroenteritis research and epidemiology(18)

Publications226 total

Newcastle Disease Virus Vaccine Strain H as a Potential Oncolytic Agent in Ovarian Cancer Therapy
Molecular Biology·2025
Metabolic Imprint of Poliovirus on Glioblastoma Cells and Its Role in Virus Replication and Cytopathic Activity
International Journal of Molecular Sciences·2025Open Access
Sesn-1 is required for lifespan extension during caloric deprivation in C. elegans through inhibition of mTORC1 and activation of autophagy
Aging·2025Open Access
Cell Carriers for Oncolytic Virus Delivery: Prospects for Systemic Administration
Cancers·2025Open Access
Cell Carriers for Oncolytic Virus Delivery: Prospects for Systemic Administration
Preprints.org·2025· 1 citedOpen Access
Moderate Metabolic Changes Are Dispensable for Replication and Oncolytic Activity of Poliovirus in Glioblastoma Cells
Preprints.org·2025Open Access
Establishment of a Panel of Human Cell Lines to Identify Cellular Receptors Used by Enteroviruses to Infect Cells
International Journal of Molecular Sciences·2025· 1 citedOpen Access
Experience of surgical treatment of pilonidal disease in children
Medical news of the North Caucasus·2025Open Access
Establishment of a Panel of Human Cell Lines to Identify Cellular Receptors Used by Enteroviruses to Infect Cells
Preprints.org·2024Open Access
Interferon type I-expressing recombinant vaccinia virus as a platform for selective immunotherapy of glioblastoma and melanoma
Bulletin of Russian State Medical University·2024· 1 citedOpen Access
126P Combination of oncolytic viruses, radiation therapy, and immune checkpoint inhibitor treatment in a breast cancer model
Immuno-Oncology Technology·2024Open Access
Receptors and Host Factors for Enterovirus Infection: Implications for Cancer Therapy
Cancers·2024· 5 citedOpen Access
Preclinical Safety Assessment of Antineoplastic Agents Based on Live Non-Pathogenic Enteroviruses
Safety and Risk of Pharmacotherapy·2024Open Access
Actin-Dependent Mechanism of Tumor Progression Induced by a Dysfunction of p53 Tumor Suppressor
Cancers·2024· 3 citedOpen Access
Effect of chemical crosslinking with glutaric aldehyde on sorption parameters of chitosan-based wound dressings
Medical news of the North Caucasus·2024Open Access
Recombinant strains of oncolytic vaccinia virus for cancer immunotherapy
Биохимия·2023Open Access
Recombinant Strains of Oncolytic Vaccinia Virus for Cancer Immunotherapy
Biochemistry (Moscow)·2023· 4 cited
Oncolytic therapy with recombinant vaccinia viruses targeting the interleukin-15 pathway elicits a synergistic response
Molecular Therapy — Oncolytics·2023· 16 citedOpen Access
Comparison of the oncolytic activity of recombinant vaccinia virus strains LIVP-RFP and MVA-RFP against solid tumors
Bulletin of Russian State Medical University·2023· 4 citedOpen Access
Data from Repression of Sestrin Family Genes Contributes to Oncogenic Ras-Induced Reactive Oxygen Species Up-regulation and Genetic Instability
2023Open Access
page 1 of 12Next →

Frequent Co-authors

Kopnin Bp(10), Anna Sablina(6), Andrei V. Budanov(6), Larissa S. Agapova(6), J. E. Kravchenko(6), Andrei V. Gudkov(6), Alexandra G. Evstafieva(5), G. V. Ilyinskaya(4), Anastasiya V. Lipatova(4), Alexey V. Ivanov(4), O. V. Matveeva(4), Lakshmi Sripada(4), Kritarth Singh(4), Paresh Prajapati(4), Rajesh Singh(4), Irina E. Kovaleva(4), Elena Feinstein(3), Valeria Ossovskaya(3), Katerina V. Gurova(3), J. M. Vasiliev(3)